These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36986759)

  • 1. Dendrimers in Alzheimer's Disease: Recent Approaches in Multi-Targeting Strategies.
    Arbez-Gindre C; Steele BR; Micha-Screttas M
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendrimers and Derivatives as Multifunctional Nanotherapeutics for Alzheimer's Disease.
    Moreira DA; Santos SD; Leiro V; Pêgo AP
    Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's Disease - Future Therapy Based on Dendrimers.
    Aliev G; Ashraf GM; Tarasov VV; Chubarev VN; Leszek J; Gasiorowski K; Makhmutovа A; Baeesa SS; Avila-Rodriguez M; Ustyugov AA; Bachurin SO
    Curr Neuropharmacol; 2019; 17(3):288-294. PubMed ID: 30227819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendrimers: Patents for Alzheimer's Disease.
    Maheshwari S; Singh A
    Recent Pat Nanotechnol; 2023 Oct; ():. PubMed ID: 37904560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.
    Volloch V; Olsen BR; Rits S
    Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer's Disease.
    Tao QQ; Lin RR; Chen YH; Wu ZY
    Aging Dis; 2022 Oct; 13(5):1391-1404. PubMed ID: 36186141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer's Disease and Identifying Promising Drug Targets.
    Fišar Z
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Mitocentric View of Alzheimer's Disease.
    Hu H; Tan CC; Tan L; Yu JT
    Mol Neurobiol; 2017 Oct; 54(8):6046-6060. PubMed ID: 27696116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of Intravenously Administered Antibodies Targeting Alzheimer's Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis.
    Tashima T
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-brain barrier Permeable nanoparticles for Alzheimer's disease treatment by selective mitophagy of microglia.
    Zhong G; Long H; Zhou T; Liu Y; Zhao J; Han J; Yang X; Yu Y; Chen F; Shi S
    Biomaterials; 2022 Sep; 288():121690. PubMed ID: 35965114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuroprotective effects of oxygen therapy in Alzheimer's disease: a narrative review.
    Yang C; Yang Q; Xiang Y; Zeng XR; Xiao J; Le WD
    Neural Regen Res; 2023 Jan; 18(1):57-63. PubMed ID: 35799509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Dysfunction and Alzheimer's Disease: Role of Microglia.
    Agrawal I; Jha S
    Front Aging Neurosci; 2020; 12():252. PubMed ID: 32973488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status and future directions of clinical trials in Alzheimer's disease.
    Plascencia-Villa G; Perry G
    Int Rev Neurobiol; 2020; 154():3-50. PubMed ID: 32739008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer's Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis.
    Bowirrat A
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed Carboxyl and Hydrophobic Dendrimer Surface Inhibits Amyloid-β Fibrillation: New Insight from the Generation Number Effect.
    Wang Z; Dong X; Sun Y
    Langmuir; 2019 Nov; 35(45):14681-14687. PubMed ID: 31635460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxycycline for Alzheimer's Disease: Fighting β-Amyloid Oligomers and Neuroinflammation.
    Balducci C; Forloni G
    Front Pharmacol; 2019; 10():738. PubMed ID: 31333460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
    Dehghani R; Rahmani F; Rezaei N
    Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease.
    Li L; Zhang J; Huang X; Du J; Tu Z; Wu H; Liu X; Yuan M
    Curr Pharm Des; 2023; 29(2):95-115. PubMed ID: 36529920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.